HJF's employee's are conducting a first-of-its-kind study to test the safety and effectiveness of a new treatment for posttraumatic headache (PTH).
The United States Army Medical Research Directorate – Africa (USAMRD-A) has conducted infectious disease surveillance and outbreak response throughout Sub-Saharan Africa with the financial support of...
Wilensky Appointed Chair and Blanck Joins HJF’s Council of Directors.
In collaboration with USU, HJF designed and produced the 2021 Centers Annual Report, which highlights the USU Centers’ impact on the Military Health System through research, education, and leadership.
A study led by HJF scientist Dr. David Priemer, found that chronic traumatic encephalopathy is uncommon in service members...
HJF received an award for OMNIBUS IV, a multiple-award, indefinite-delivery/indefinite-quantity contract that will provide military medical research
HJF has donated $30,000 to Global Surgical and Medical Support Group (GSMSG) to support the Lviv Visiting Surgeon Program
To help service members make informed decisions about dietary supplement use, a new Department of Defense Instruction, DoDI 6130.06
2022 Hero of Military Medicine Ambassador Award Announcement
Military medical researchers have identified specific inherited, or “germline,” gene mutations associated with prostate cancer development specific to African American men.
In a new article, researchers from the Center for Prostate Disease Research demonstrated a new method to treat drug-resistant prostate disease.
Volumetric muscle loss is frequently found in Service members with traumatic limb injuries.
CAMRIS International, LLC, an HJF Company, today announced its involvement in COVID-19 vaccine research by the Walter Reed Army Institute of Research.
Annabel Lee Raboy, MSW, received the Best Poster Presentation award during the inaugural Defense Intrepid Network Research Symposium.
